Phase
Condition
Atopic Dermatitis
Allergy
Eczema (Atopic Dermatitis)
Treatment
Cetaphil® Restoraderm® body wash
Cetaphil® Restoraderm® moisturizer + Cetaphil® Restoraderm® body wash
Clinical Study ID
Ages 2-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male or female subject, aged 2 to 12 years inclusive
- Controlled mild to moderate atopic dermatitis with a Investigator Global Assessmentscore at 0 or 1, within one week after successful treatment with topicalcorticosteroid.
Exclusion
Exclusion Criteria:
- Subject presenting bacterial, viral, fungal or parasite skin infection
- Subject with ulcerated lesions, acne or rosacea
- Immunosuppression
- Subject with a wash-out period from baseline for topical treatment less than 8 daysfor Calcineurin inhibitor
- Subject with a wash-out period from baseline for topical treatment more than 8 daysfor corticosteroid
- Subject with a wash-out period from baseline for systemic treatment less than 8 daysfor anti-histamines, less than 4 weeks for immunomodulators
Study Design
Study Description
Connect with a study center
Department of Dermatology /Shenzhen Children's hospital
Shenzhen, Guangdong 518026
ChinaSite Not Available
Hunan Children's Hospital
Hunan, Hunan 410007
ChinaSite Not Available
XinHua Hospital
Yangpu, Shanghai 200092
ChinaSite Not Available
Department of Dermatology /Beijing Children's Hospital
Beijing, XI Cheng 100045
ChinaSite Not Available
Philippine General Hospital
Manila, Ermita 1000
PhilippinesSite Not Available
Asian Hospital and Medical Center
Manila, Muntinlupa City 1780
PhilippinesSite Not Available
St. Luke's Medical Center
Taguig, Taguig City 1634
PhilippinesSite Not Available
Jose R. Reyes Memorial Medical Center
Manila, 1003
PhilippinesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.